The investment round was led by Partech and OTB Ventures with support from Acclimate Ventures and existing backers.
"We are at an exciting point in time where powerful Vision LLMs are now both accurate and cost efficient enough to open up valuable new use cases, thanks to our combination of on-device Tiny AI with cloud-based Vision LLMs. We’re going to make it possible for everyone to have their own AI security guard and assistant that never gets distracted, so they feel safer and calmer than ever before. It will warn you about a stranger in your backyard, a leaking water pipe, or simply help you find your keys. And it’s not just for the home, but for retail, offices, warehouses, elderly care and more. The trust of our partners and investors allows us to bring powerful AI into the physical world, beyond desktops and the cloud."
The financing round was backed by BGF, Parkwalk, and Meltwind to drive therapeutics discovery in autoimmune and other common diseases.
"Our founders have led the field by developing technology to map 3D interactions on a whole-genome scale, and integrating these data with comprehensive multi-omics datasets. We now have the technological capabilities to decipher the causal biology that drives complex and common genetic diseases, with the potential to develop truly effective new blockbuster therapies."
The financing was co-led by New Enterprise Associates and Temasek with participation from a broad group of strategic investors.
"Next-generation AI compute, clean air and water and sustainable energy – these multi-billion-dollar global challenges share a common barrier: materials. CuspAI’s mission is to change that. In just a year, we’ve gone from concept to partnerships with world leaders in automotive, semiconductors, energy, and climate."
The Series A round was led by Notion Capital with participation from multiple venture firms and angel investors.
"Every Trust we meet tells us the same story: they need qualified staff now, but they cannot risk patient safety or compliance. Our platform gives them speed without compromise, predictability without cost inflation, and sustainability where locum dependency has become unsustainable. TERN Group’s mission is for every placement to set off a chain reaction: anurse arriving on time means a ward runs smoothly, which means patients get treated faster. This raise enables us to make those chain reactions happen at scale, across the UK and beyond."
